Enterprise Value
-28.78M
Cash
109.4M
Avg Qtr Burn
-10.44M
Short % of Float
0.23%
Insider Ownership
26.65%
Institutional Own.
68.47%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
ETX-123 (Kv7.2/3 channel opener) Details Epilepsy, Pain, Seizures | Phase 1 Initiation | |
ETX-810 Details Chronic pain, Pain, Sciatica | Failed Discontinued | |
ETX-810 Details Chronic pain, Sciatica , Pain, Diabetes | Failed Discontinued | |
ETX-155 Details Epilepsy | Failed Discontinued | |
ETX-155 Details Major depressive disorder, Perimenopausal Depression | Failed Discontinued |